A 25-year-old patient receiving acetylcysteine for immediate-release paracetamol poisoning develops a rash, urticaria, and flushing shortly after the infusion starts. According to the guidelines, what is the appropriate management for this immediate immune-mediated (non-IgE) hypersensitivity reaction ?